pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

18,618 catalysts · 4,728 grant · 3,674 8k filing · 2,621 approval · 2,129 device 510k · 1,725 device recall · 1,490 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 19 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts2026-11-23: 0 catalysts2026-11-24: 0 catalysts2026-11-25: 0 catalysts2026-11-26: 0 catalysts2026-11-27: 0 catalysts2026-11-28: 0 catalysts2026-11-29: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-08-12×clear all
type
  • grant4,728
  • 8k filing3,674
  • approval2,621
  • device 510k2,129
  • device recall1,725
  • device pma1,490
  • device adverse event1,000
  • recall586
  • earnings585
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Jan 12, 2026

    39
    ›Jan 16, 2026device recall230d agoIntegra LifeSciences Corp. (NeuroSciences) device recall (Cls II)INTEGRA LIFESCIENCES HOLDINGS CORP

    MEDIHONEY CALCIUM ALGINATE WITH ACTIVE LEPTOSPERMUM HONEY. Model Numbers: (1) 31012, (2) 31022, (3) 31045. MEDIHONEY CALCIUM ALGINATE DRESSING WITH ACTIVE LEPTOSPERMUM HONEY supports and aids autolytic debridement and is indicated for the management of moderately to heavily exuding wounds — Reason: Potential packaging failures, which could lead to a breach in the sterile barrier. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 16, 2026device recall230d agoOlympus Corporation of the Americas device recall (Cls I)

    Olympus High Flow Insufflation Unit. Model Number: UHI. Used for insufflation of the abdominal cavity, and automatic suction and smoke evacuation to facilitate laparoscopic observation and treatment within the abdominal cavity. — Reason: Issue with software algorithm which may lead to overpressure events. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 16, 2026grant230d agoOREGON HEALTH & SCIENCE UNIVERSITY — Intraductal gene therapy for liver cirrhosis.

    DK grant. $686,129. PI: Markus Grompe

    full page →nih reporter ↗
    ›Jan 16, 2026grant230d agoUNIVERSITY OF FLORIDA — Investigating the roles of extracellular pyruvate in regulating Streptococcus...University of Florida

    DE grant. $419,375. PI: Kelly Christine Rice

    full page →nih reporter ↗
    ›Jan 16, 2026grant230d agoCOLUMBIA UNIVERSITY HEALTH SCIENCES — A Synaptic Basis for Dopamine-Driven Reinforcement Learning in Cortex

    NS grant. $126,900. PI: Eddy Albarran

    full page →nih reporter ↗
    ›Jan 16, 2026grant230d agoSMITH-KETTLEWELL EYE RESEARCH INSTITUTE — Computational Modelling of Perceptual Information Accumulation in Blind Indiv...

    EY grant. $76,120. PI: Sofia Krasovskaya

    full page →nih reporter ↗
    ›Jan 16, 2026grant230d agoYALE UNIVERSITY — Investigating the Role of Epstein-Barr Virus in Long COVID Pathogenesis

    AI grant. $33,538. PI: Alexandra Tabachnikova

    full page →nih reporter ↗
    ›Jan 16, 2026grant230d agoCHILDREN'S HOSP OF PHILADELPHIA — Microfracture-based Repair for Temporomandibular Joint Osteoarthritis

    DE grant. $78,840. PI: Hagar Kenawy

    full page →nih reporter ↗
    ›Jan 16, 2026grant230d agoBOSTON CHILDREN'S HOSPITAL — Dissecting Neural Circuits for Top-Down Control of Sympathetic FunctionsBoston Children's Hospital

    NS grant. $674,950. PI: ZHIGANG HE

    full page →nih reporter ↗
    ›Jan 16, 2026grant230d agoTEMPLE UNIV OF THE COMMONWEALTH — Voice-activated antibacterial piezoelectric composites for dental restorations

    DE grant. $435,875. PI: Santiago Orrego

    full page →nih reporter ↗
    ›Jan 16, 2026grant230d agoBROWN UNIVERSITY — Investigating the Role of AIMP2 in Cardiac Stress Responses

    HL grant. $49,538. PI: Vasundhara Singh

    full page →nih reporter ↗
    ›Jan 17, 2026approval229d agoDOXYCYCLINE — FDA approvalPrasco LLC

    Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval229d agoDOXYCYCLINE — FDA approvalPrasco LLC

    Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval229d agoDOXYCYCLINE — FDA approvalPrasco LLC

    Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval229d agoDOXYCYCLINE — FDA approvalPrasco LLC

    Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval229d agoDOXYCYCLINE — FDA approvalPrasco LLC

    Sponsor: SUN PHARM INDS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval229d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval229d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval229d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval229d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval229d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval229d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval229d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval229d agoCLINDAMYCIN HYDROCHLORIDE — FDA approvalMicro Labs USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval229d agoPOTASSIUM CHLORIDE 0.22% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (POTASSIUM CHLORIDE) — FDA approvalUpsher-Smith Laboratories LLC

    Sponsor: B BRAUN. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Jan 17, 2026approval229d agoDOXYCYCLINE — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval229d agoDOXYCYCLINE — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026approval229d agoDOXYCYCLINE — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 17, 2026device 510k229d agoMedtronic, Ireland — Sprinter Legend Rapid Exchange Balloon Dilatation Catheter (510k cleared)

    Product code: LOX. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 17, 2026device 510k229d agoAuxilium Biotechnologies, Inc. — NeuroSpan Bridge (510k cleared)AXIM BIOTECHNOLOGIES, INC.

    Product code: JXI. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 17, 2026grant229d agoHARVARD UNIVERSITY — From Exploration to Expertise: Mechanisms of Motor Learning in Cortico-Basal ...

    NS grant. $120,582. PI: Kiah Hardcastle

    full page →nih reporter ↗
    ›Jan 18, 2026approval228d agoTOPIRAMATE — FDA approvaltopiramate ER

    Sponsor: GLENMARK PHARMS LTD. Form: CAPSULE. Route: ORAL

    full page →topiramate ER →fda approvals ↗
    ›Jan 18, 2026approval228d agoAMBRISENTAN — FDA approvalSigmapharm Laboratories LLC

    Sponsor: SUN PHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 18, 2026approval228d agoAMBRISENTAN — FDA approvalSigmapharm Laboratories LLC

    Sponsor: SUN PHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 18, 2026approval228d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: MYLAN. Form: TABLET. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Jan 18, 2026approval228d agoDILTIAZEM HYDROCHLORIDE — FDA approvalBausch Health US LLC

    Sponsor: AMTA. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 18, 2026device 510k228d agoBiosense Webster, Inc. — CARTO™ 3 EP Navigation System V9.0 with PIU Plus (510k cleared)

    Product code: DQK. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Jan 18, 2026device 510k228d agoBaylis Medical Technologies, Inc. — Baylis Connector Cable (510k cleared)Medical Care Technologies Inc.

    Product code: DSA. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Jan 18, 2026grant228d agoDUKE UNIVERSITY — Mechanisms of the small nucleolar RNA Snord67 in breast cancer lymphatic meta...Duke University

    CA grant. $87,964. PI: Katherine Ismei Zhou

    full page →nih reporter ↗

    Week of Jan 19, 2026

    11
    ›Jan 19, 2026approval227d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: HQ SPECLT PHARMA. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Jan 19, 2026approval
    ← prev
    page 169 of 373
    next →
    227d ago
    AMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: HQ SPECLT PHARMA. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Jan 19, 2026approval227d agoGLYCOPYRROLATE — FDA approvalFresenius Kabi USA LLC

    Sponsor: SUN PHARM INDS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 19, 2026approval227d agoGLYCOPYRROLATE — FDA approvalFresenius Kabi USA LLC

    Sponsor: CHARTWELL RX. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 19, 2026grant227d agoGORDON RESEARCH CONFERENCES — 2026 Bones and Teeth Gordon Research Conference and Gordon Research Seminar

    AR grant. $15,000. PI: JOY Y WU

    full page →nih reporter ↗
    ›Jan 20, 2026approval226d agoZEPBOUND (TIRZEPATIDE) — FDA approvalZEPBOUND

    Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →ZEPBOUND →fda approvals ↗
    ›Jan 20, 2026approval226d agoMIRABEGRON — FDA approvalAstellas Pharma US Inc

    Sponsor: ALKEM LABS LTD. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 20, 2026approval226d agoZIRGAN (GANCICLOVIR) — FDA approvalganciclovir

    Sponsor: BAUSCH AND LOMB. Form: GEL. Route: OPHTHALMIC

    full page →ganciclovir →fda approvals ↗
    ›Jan 20, 2026approval226d agoSERTRALINE HYDROCHLORIDE — FDA approvalGreenstone LLC

    Sponsor: UMEDICA. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 20, 2026approval226d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: HIKMA INTL PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 20, 2026approval226d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: HIKMA INTL PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    $IART16.81+1.14%
    $AXIM
    $MDCE0.00020.00%
    $PYPD5.3000-0.56%
    $PYPD5.3000-0.56%
    $LLY1160.00+0.28%
    $BLCO18.14+1.43%